Angiotensin II activates MCP-1 and induces cardiac hypertrophy and dysfunction via toll-like receptor 4
- Susumu Matsuda,
- Seiji Umemoto(corresponding author),
- Koichi Yoshimura,
- Shinichi Itoh,
- Tomoaki Murata,
- Tohru Fukai
- Yamaguchi University,
- University of Illinois at Chicago
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOpen access
Abstract
<p>Aim: Angiotensin Ⅱ (AngⅡ) produces reactive oxygen species (ROS), thus contributing to the development of cardiac hypertrophy and subsequent heart failure, and stimulates the expression of monocyte chemoattractant protein-1 (MCP-1). In addition, Toll-like receptor 4 (TLR4) is involved in the upregulation of MCP-1. In order to clarify whether TLR4 is involved in the onset of cardiac dysfunction caused by AngⅡ stimulation, we investigated the effects of TLR4 on oxidative stress, the MCP-1 expression and cardiac dysfunction in mice with AngⅡ-induced hypertension. Methods: TLR4-deficient (Tlr4<sup>lps-d</sup>) and wild-type (WT) mice were randomized into groups treated with AngⅡ, norepinephrine (NE) or a subdepressor dose of the AngⅡ receptor blocker irbesartan (IRB) and AngⅡ for two weeks. Results: AngⅡ and NE similarly increased systolic blood pressure in all drug-treated groups compared to that observed in the control group among both WT and Tlr4<sup>lps-d</sup> mice (p<0.05). In the WT mice, AngⅡ induced cardiac hypertrophy as well as vascular remodeling and perivascular fibrosis of the intramyocardial arteries and monocyte/macrophage infiltration in the heart (p<0.05). Furthermore, AngⅡ treatment decreased the left ventricular diastolic function and resulted in a greater left ventricular end-systolic dimension (p<0.05) in addition to producing a five-fold increase in the NADPH oxidase activity, ROS content and MCP-1 expression (p<0.05). In contrast, the Tlr4<sup>lps-d</sup> mice showed little effects of AngⅡ on these indices. In the WT mice, IRB treatment reversed these changes compared to that seen in the mice treated with AngⅡ alone. NE produced little effect on any of the indices in either the WT or Tlr4<sup>lps-d</sup> mice. Conclusions: TLR4 may be involved in the processes underlying the increased oxidative stress, selectively activated MCP-1 expression and cardiac hypertrophy and dysfunction seen in cases of AngⅡ- induced hypertension.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 833-844 (12 pages)Journal (Volume, Issue Number)
Journal of Atherosclerosis and Thrombosis (Volume 22, Issue 8)Publication milestones
- Published - 08/26/2015
Publication status
Published - 08/26/2015
ISSN
1340-3478Publication IDs
- Scopus: 84940387844
- PubMed: 25752363
Publication metrics
Metrics
Fractional count
1
Fractional count
0.14
Fractional count
6
Fractional count
0.86
Fractional count
1
Fractional count
1
SciVal
citations
40
SciVal
FWCI
1.91
SciVal
Author count
7
SciVal
Paper percentile
93
SciVal
Top percentile
10
PlumX, opens in new tab
Captures
53
Citation count
64
Funding Details
FunderFunding number
VA
I01BX001232
